Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06592495 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

StatusUnknown
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 23, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Interventions: DWC202315 (Drug), Intervention: DWJ1589 (Drug) to Period 1 (Drug), Period 2 (Drug), Period 3 (Drug), Period 4 (Drug)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the safety and pharmacokinetic characteristics after administration of DWJ1589 and DWC202315 in healty adult volunteers.
Trial Details
NCT Number NCT06592495
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy Volunteers
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov